Cited 35 times in
HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.